FilingSEC EDGAR6-K
Nasus Pharma Approves All Agenda Items Except Proposal No. 4 at General Meeting
· SEC accepted
StageShareholder Meeting Results
Filing content
Nasus Pharma held its Annual and Special General Meeting on October 8, 2026, and approved all agenda items except for Proposal No. 4.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…